How Monoclonal Antibodies and Vaccines Are Shaping the Product Landscape
The GCC Downstream Processing market is expanding as biopharmaceutical manufacturers invest in advanced purification and separation technologies to address the rising incidence of chronic diseases and improve patient outcomes. The market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.0 billion by 2035, growing at a CAGR of 7.2%. The GCC Downstream Processing Market...
0 Comments 0 Shares 25 Views 0 Reviews